drugset / Trial / NCT00185055

The Relative Effects of Olmesartan Medoxomil, Irbesartan and Valsartan on the Activity of the Blood Pressure Control System in Healthy Subjects

NCT00185055

Phase 4 Completed 20 enrolled Daiichi Sankyo
RandomizedCrossoverSingle-blindTreatment

Summary

To assess the effects of 3 blood pressure drugs, called angiotensin receptor blockers, on the blood pressure control systems in healthy subjects.

Timeline

Start
2004-11
Primary completion
Completion
2005-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Irbesartan Small molecule
Subject Olmesartan medoxomil Unknown
Subject Valsartan Small molecule

Indications

No indication recorded.